HVCN1 and neoplasm: Finally, the use of Hvcn1 inhibitors has been suggested as a potential therapeutic approach to malignancies, many of which aberrantly express this proton channel, likely as a mechanism of survival in the highly acidic tumor microenvironment (16, 44).